Acute aldosterone antagonism improves cardiac vagal control in humans.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Fletcher, JanineBuch, Ashesh N.
Routledge, Helen C.
Chowdhary, Saqib
Coote, John H.
Townend, Jonathan N.
Issue Date
2004
Metadata
Show full item recordAbstract
OBJECTIVES: We have examined the acute effects (<45 min) of aldosterone antagonism on heart rate variability and baroreflex sensitivity, markers of cardiac vagal control, in 13 healthy subjects. BACKGROUND: Evidence for the beneficial effects of aldosterone antagonists comes from studies showing increased survival rates following their addition to standard heart failure therapy. Many mechanisms have been suggested for this action, including effects upon the autonomic nervous system. METHODS: Heart rate variability and baroreflex sensitivity were examined 30 min following the administration of potassium canrenoate (intravenous) (aldosterone antagonist) or saline (control). RESULTS: Active treatment reduced resting heart rate (-6 +/- 1 beats/min [mean +/- standard error mean]) compared to control (0 +/- 1 beat/min) (p < 0.001) and increased measures of high frequency (HF) heart rate variability. Root mean square of successive RR interval differences increased by 21 +/- 5 ms versus -6 +/- 5 ms control (p < 0.001); HF power increased by 1,369 +/- 674 ms(2)with aldosterone antagonism compared to -255 +/- 431 ms(2) following saline infusion (p < 0.01). Baroreflex sensitivity (alpha-HF) was increased after active treatment (+4 +/- 2 ms/mm Hg vs. 0 +/- 1 ms/mm Hg control [p < 0.05]). No changes in plasma potassium levels were observed. CONCLUSIONS: These results provide evidence that aldosterone antagonists acutely improve cardiac vagal control, irrespective of any diuretic effects, and may in part explain their beneficial effects in treatment of heart failure.Citation
Journal of the American College of Cardiology, 43(7): 1270-1275Publisher
Elsevier BVPubMed ID
15063441Type
Journal articleLanguage
enDescription
Metadata onlyISSN
0735-1097ae974a485f413a2113503eed53cd6c53
10.1016/j.jacc.2003.10.058
Scopus Count
Collections
Related articles
- Nitric oxide and cardiac parasympathetic control in human heart failure.
- Authors: Chowdhary S, Ng GA, Nuttall SL, Coote JH, Ross HF, Townend JN
- Issue date: 2002 Apr
- Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans.
- Authors: Heindl S, Holzschneider J, Hinz A, Sayk F, Fehm HL, Dodt C
- Issue date: 2006 Feb
- Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic beta-blockers on human cardiac vagal control.
- Authors: Vaile JC, Fletcher J, Al-Ani M, Ross HF, Littler WA, Coote JH, Townend JN
- Issue date: 1999 Nov
- Effect of verapamil on baroreflex sensitivity and on cardiovascular variability.
- Authors: Gmitrov J, Andrejko S
- Issue date: 2000 Feb 25
- Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism.
- Authors: Schmidt BM, Horisberger K, Feuring M, Schultz A, Wehling M
- Issue date: 2005 May